Compare M&T Bank Corporation (MTB) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Summit Therapeutics Inc — how do they compare? M&T Bank Corporation trades at $251.93 (market cap $36.42B), while Summit Therapeutics Inc trades at $15.4 (market cap $12.06B). The key difference: M&T Bank Corporation is far larger — about 3× Summit Therapeutics Inc's market cap, and M&T Bank Corporation pays a 2.38% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MTB | SMMT | |
|---|---|---|
Market Cap | $36.42B | $12.06B |
Sector | Financials | Health |
52-Week High | $254.04 | $26.98 |
52-Week Low | $178.63 | $12.55 |
Dividend Yield | 2.38% | — |
Enterprise Value | — | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
